Literature DB >> 20449696

Minimally invasive therapies for chronic pelvic pain syndrome.

Salim A Wehbe1, Jennifer Y Fariello, Kristene Whitmore.   

Abstract

Chronic pelvic pain syndrome (CPPS) is a common problem among men and women worldwide. It is a symptoms-complex term for interstitial cystitis/painful bladder syndrome in women and chronic prostatitis/chronic pelvic pain syndrome in men. Patients often present with a combination of lower urinary tract symptoms with pelvic pain and sexual dysfunction. No gold standard exists for diagnosis or treatment of CPPS. The diagnosis is often challenging and is determined by elimination. Multiple treatment modalities exist, ranging from physical therapy to surgery. We discuss minimally invasive therapies for treatment of this complex of symptoms. Although data suggest reasonable efficacy of several medications, multimodal therapy remains the mainstay of treatment. We review the following minimally invasive therapeutic modalities: dietary modifications, physical therapy, mind-body therapies, medical therapy, intravesical therapies, trigger point injections, botulinum toxin injections to the pelvic floor, and neuromodulation. We report data supporting their use and efficacy and highlight the limitations of each.

Entities:  

Mesh:

Year:  2010        PMID: 20449696     DOI: 10.1007/s11934-010-0120-x

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  73 in total

Review 1.  Behavioral treatment for chronic low back pain: a systematic review within the framework of the Cochrane Back Review Group.

Authors:  M W van Tulder; R Ostelo; J W Vlaeyen; S J Linton; S J Morley; W J Assendelft
Journal:  Spine (Phila Pa 1976)       Date:  2000-10-15       Impact factor: 3.468

2.  Behavioral treatment of chronic low back pain. I. Relation of coping strategy use to outcome.

Authors:  Philip Spinhoven; Corry G A Linssen
Journal:  Pain       Date:  1991-04       Impact factor: 6.961

3.  Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.

Authors:  Jason A Abbott; Sherin K Jarvis; Stephen D Lyons; Angus Thomson; Thierry G Vancaille
Journal:  Obstet Gynecol       Date:  2006-10       Impact factor: 7.661

4.  Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study.

Authors:  Craig V Comiter
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

5.  Chronic pudendal nerve neuromodulation in women with idiopathic refractory detrusor overactivity incontinence: results of a pilot study with a novel minimally invasive implantable mini-stimulator.

Authors:  Jan Groen; Christophe Amiel; J L H Ruud Bosch
Journal:  Neurourol Urodyn       Date:  2005       Impact factor: 2.696

Review 6.  Pentosan polysulfate: a review of its use in the relief of bladder pain or discomfort in interstitial cystitis.

Authors:  Vanessa R Anderson; Caroline M Perry
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 7.  Role of alpha-blockers in type III prostatitis: a systematic review of the literature.

Authors:  Vibhash C Mishra; John Browne; Mark Emberton
Journal:  J Urol       Date:  2007-01       Impact factor: 7.450

8.  Biofeedback is effective treatment for levator ani syndrome.

Authors:  S M Heah; Y H Ho; M Tan; A F Leong
Journal:  Dis Colon Rectum       Date:  1997-02       Impact factor: 4.585

9.  Pudendal nerve neuromodulation with neurophysiology guidance: a potential treatment option for refractory chronic pelvi-perineal pain.

Authors:  Maude Carmel; Michel Lebel; Le Mai Tu
Journal:  Int Urogynecol J       Date:  2009-12-12       Impact factor: 2.894

10.  Electroacupuncture relieves pain in men with chronic prostatitis/chronic pelvic pain syndrome: three-arm randomized trial.

Authors:  Sang-Hun Lee; Byung-Cheol Lee
Journal:  Urology       Date:  2009-05       Impact factor: 2.649

View more
  5 in total

Review 1.  Recognition and management of nonrelaxing pelvic floor dysfunction.

Authors:  Stephanie S Faubion; Lynne T Shuster; Adil E Bharucha
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  New directions in the treatment of pelvic pain.

Authors:  Mercy A Udoji; Timothy J Ness
Journal:  Pain Manag       Date:  2013-09

3.  An international Urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction.

Authors:  Rebecca G Rogers; Rachel N Pauls; Ranee Thakar; Melanie Morin; Annette Kuhn; Eckhard Petri; Brigitte Fatton; Kristene Whitmore; Sheryl A Kingsberg; Joseph Lee
Journal:  Int Urogynecol J       Date:  2018-03-26       Impact factor: 2.894

Review 4.  Complementary and alternative medical therapies for interstitial cystitis: an update from the United States.

Authors:  Megan Danielle Atchley; Nima M Shah; Kristene E Whitmore
Journal:  Transl Androl Urol       Date:  2015-12

Review 5.  Complementary and Alternative Medicine in the Treatment of Chronic Pelvic Pain in Women: What Is the Evidence?

Authors:  Sara Paiva; Márcia Mendonça Carneiro
Journal:  ISRN Pain       Date:  2013-11-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.